Philogen S.p.a.
Clinical trials sponsored by Philogen S.p.a., explained in plain language.
-
New hope for skin cancer patients who failed standard treatment
Disease control Not yet recruitingThis study tests an experimental injection treatment for people with advanced skin cancer that has continued to grow despite standard immunotherapy. The treatment involves weekly injections directly into tumors for up to four weeks, with possible additional treatment if the cance…
Phase: PHASE2 • Sponsor: Philogen S.p.A. • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC
-
Experimental injection offers hope for Tough-to-Treat skin cancer
Disease control Not yet recruitingThis study is testing a new injection treatment for people with advanced basal cell carcinoma, a type of skin cancer, who haven't responded well to or can't tolerate standard treatments. The treatment involves weekly injections directly into the tumors for up to four weeks, with …
Phase: PHASE2 • Sponsor: Philogen S.p.A. • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC
-
Needle-Based hope for inoperable skin cancer
Disease control Not yet recruitingThis study is testing three different experimental injections for people with a locally advanced form of skin cancer called basal cell carcinoma who cannot have or refuse surgery or radiation. About 180 participants will receive weekly injections directly into their tumor for fou…
Phase: PHASE2 • Sponsor: Philogen S.p.A. • Aim: Disease control
Last updated Mar 23, 2026 15:18 UTC